Cargando…
PIM1 and CD79B Mutation Status Impacts the Outcome of Primary Diffuse Large B-Cell Lymphoma of the CNS
Primary diffuse large B cell lymphoma of the central nervous system (CNS DLBCL) is a rare malignancy with a distinct genetic profile. The clinicopathological significance of the mutation patterns remains unknown. Forty cases of primary CNS DLBCL were subjected to targeted exome sequencing covering 4...
Autores principales: | Zhou, Jihao, Zuo, Min, Li, Lifeng, Li, Fang, Ke, Peng, Zhou, Yangying, Xu, Yaping, Gao, Xuan, Guan, Yanfang, Xia, Xuefeng, Yi, Xin, Zhang, Xinyou, Huang, Yuhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864287/ https://www.ncbi.nlm.nih.gov/pubmed/35223507 http://dx.doi.org/10.3389/fonc.2022.824632 |
Ejemplares similares
-
Diffuse large B cell lymphomas relapsing in the CNS lack oncogenic MYD88 and CD79B mutations
por: Kersten, M J, et al.
Publicado: (2014) -
Control of translational activation by PIM kinase in activated B-cell diffuse large B-cell lymphoma confers sensitivity to inhibition by PIM447
por: Peters, Tara L., et al.
Publicado: (2016) -
Role and mechanism of PIM family in the immune microenvironment of diffuse large B cell lymphoma
por: Wang, Changying, et al.
Publicado: (2023) -
PIM1 genetic alterations associated with distinct molecular profiles, phenotypes and drug responses in diffuse large B‐cell lymphoma
por: Zhang, Huilai, et al.
Publicado: (2022) -
PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma
por: Brault, L, et al.
Publicado: (2012)